Post

What do GWAS and rare variant burden tests discover, and why? Do these studies find the most IMPORTANT genes? If not, how DO they rank genes? Here we present a surprising result: these studies actually test for SPECIFICITY! A 🧵on what this means... (🧪🧬) www.biorxiv.org/content/10.1...

biorxiv.orgSpecificity, length, and luck: How genes are prioritized by rare and common variant association studiesStandard genome-wide association studies (GWAS) and rare variant burden tests are essential tools for identifying trait-relevant genes. Although these methods are conceptually similar, we show by anal...

GWAS and burden tests are conceptually similar, so we might expect them to prioritize genes similarly. We find that their prioritizations of genes are surprisingly discordant (even when trying to get them to match as much as possible!) 2/n

If GWAS and burden rank genes differently, then how exactly are they ranking genes? More fundamentally, if we could measure whatever we wanted about genes, how SHOULD we rank genes? We propose two possible criteria: trait importance and trait specificity. 3/n

Trait importance is how much of an effect a gene has on the study trait. Genes with big effects should be ranked highly. But what if a gene has huge effects across a ton of traits? Should a gene that affects everything still be ranked highly? 4/n

0 reposts4 likes

Maybe instead, one might want to rank genes by their trait specificity – how important they are for the study trait relative to how important they are across all traits. A trait-specific gene might better capture how “core” it is to trait biology. 5/n

We developed theory to understand what determines burden test gene ranking: surprisingly, these rank by SPECIFICITY! We confirmed this in practice in UKB. This is surprising! Burden tests don’t rank genes by their importance! 6/n

What about GWAS? GWAS prioritize genes near trait-specific VARIANTS. This is profoundly different from prioritizing trait-specific GENES. Variants can be specific because they act on trait-specific genes, or because they act on pleiotropic genes in a context-specific way. 8/n

I don't think I understand what you mean by "core" here. More broadly, I think trying to define "core" vs" non-core" may be a mirage. It feels a bit like asking what contributes most to Usain Bolt's speed: left leg, right leg, heart or nervous system. 1/n

The specificity question you drill into here strikes me as being key when it comes to *interventions*. It answers the question, "is there anything I can do that will selectively modify just this one trait" 2/n

Moreover, the two types of test answer that question for different audiences. Burden tests may be most medically relevant to pharma companies (i.e. drug development). They tell you which genes you can target with drugs or gene edits to have a specific effect on the trait of interest. 3/n